The evaluation of the effect of pentoxifylline on diabetic foot ulcers
Phase 2
- Conditions
- Diabetes mellitus.Diabetes mellitus due to underlying condition
- Registration Number
- IRCT20180818040823N1
- Lead Sponsor
- Tehran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Male
- Target Recruitment
- 18
Inclusion Criteria
Being Diabetic for more than 5 years
male patients
Candidate for pentoxifylline based on endocrinologist diagnosis
Exclusion Criteria
History of diabetic foot ulcer
patient dissatisfaction with enrollment
History of macro or microvascular complications of diabetes (proliferative retinopathy, myocardial infarction, stroke, renal failure requiring dialysis)
Impossibility of dorsal and plantar flexion of the foot
History of any trauma, tumor or other disease in the lower extremities
Study & Design
- Study Type
- observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Increased perfusion reserve of the lower extremities. Timepoint: Imaging was performed at the beginning of the study (before the intervention) and 4 to 6 weeks after taking the Medication. Method of measurement: Gamma camera imaging.
- Secondary Outcome Measures
Name Time Method